MAIN MENU
QUICK LINKS
CONNECT WITH US

Button
Coronavirus (COVID-19) updates, visitor restrictions and resources →
Now offering telemedicine through our Virtual Visit online program for primary care and specialty care visits → Virtual Visit appointments are available for new and existing UF Health patients. Check the FAQ section and Request an Appointment section below for more information.

Call (904) 383-1052 to make an appointment or call your physician’s office if you have questions specific to your health needs.

Clinical Trial Details

Title
COBRA 2015-01 Randomized Trial of Cobra PzF Stenting to Reduce Duration of Triple Therapy (COBRA-REDUCE)
Study Description

The purpose of the study is to collect information about the safety and effectiveness of the COBRA PzF Coronary Stent System in the treatment of de novo lesions in native coronary arteries with a shortened duration of dual antiplatelet therapy

Investigational Treatment: The COBRA PzF™ Coronary Stent System (CeloNova BioSciences, San Antonio, Texas) is a balloon-expandable bare metal coronary stent (a tube like to keep your artery open to allow blood flow to your heart) coated with a thin layer of novel Polyzene-F polymer with 14 days of dual antiplatelet therapy (blood thinner) after stenting. Control Treatment: The control treatment is a commercially available drug eluting stent (Xience/Promus or Resolute) with 6 months of dual antiplatelet therapy after stenting

Open Enrollment
Contact Name: Andrea Goosen
Contact Phone: (904) 244-5632
Contact Email: Andrea.Goosen@jax.ufl.edu
Investigators

Principal Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Theodore A. Bass, M.D.
Medicine

Sub Investigator
Daniel Soffer, M.D.
Medicine

Sub Investigator
Siva Suryadevara, M.B.B.S. (M.D.)
Medicine

Sub Investigator
Martin "M" Zenni, M.D.
Medicine